Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Real-World Atopic Dermatitis: Italian Insights Grant
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Promoting Pain Treatment in Osteoarthritis Care
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    Developing Clinical Research and Publication Skills(Asia, AfME, Latin America and China)
    Release Date:
    Partner: British Medical Journal (BMJ)
    Review Process: Expert Review Panel
    Education Internal Medicine All
    A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color
    Release Date:
    Partner: Conquer Cancer, The ASCO Foundation
    Review Process: Expert Review Panel
    Research Oncology USA
    PCF-Pfizer-Myovant Relugolix Challenge Awards
    Release Date:
    Partner: The Prostate Cancer Foundation and Myovant Sciences GmbH
    Review Process: Expert Review Panel
    Research Oncology USA
    BRAF-mutation Biomarker Testing in Colorectal Cancer and Melanoma
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Oncology Canada
    Pfizer Innovation Challenge: Patient Preference Database Blueprint
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Management of Uterine Fibroids and Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    COVID-19 Impact and SARS-CoV-2 Viral Lifecycle
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Addressing Knowledge Gaps on Biosimilar Use in Inflammatory Conditions
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Dermatology Research Fellowship in Skin of Color
    Release Date:
    Partner: Skin of Color Society
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All